Envoy Medical (COCH) Interest Expenses (2021 - 2026)

Envoy Medical (COCH) has 6 years of Interest Expenses data on file, last reported at $264000.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 46.67% year-over-year to $264000.0; the trailing twelve-month figure through Mar 2026 stood at $264000.0 (up 102.15% YoY), and the FY2025 full-year result was $1.6 million, down 67.92% from the prior year.
• Interest Expenses fell to $264000.0 in Q1 2026, from $471000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.9 billion in Q3 2024 to a low of -$13.3 million in Q4 2023.
• A 5-year average of $149.0 million and a median of $495000.0 in 2025 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 2157.98% in 2023 and surged 264280.29% in 2024, its largest moves.
• Tracing COCH's Interest Expenses over 5 years: stood at $645000.0 in 2022, then slumped by 2157.98% to -$13.3 million in 2023, then surged by 102.89% to $384000.0 in 2024, then grew by 22.66% to $471000.0 in 2025, then tumbled by 43.95% to $264000.0 in 2026.
• Business Quant data shows COCH's Interest Expenses at $264000.0 in Q1 2026, $471000.0 in Q3 2025, and $624000.0 in Q2 2025.